Results analysis from Kepler Trust Intelligence

BH Macro Limited
02 October 2024
 

BH Macro (BHMG)

02/10/2024

Results analysis from Kepler Trust Intelligence

The NAV per share performance in the six-month period to 30/06/2024 has been slightly negative, being -1.10% for the Sterling share class and -1.54% for the US Dollar share class. As at the time of writing, the most recent NAV reflects a significant improvement from this position, with the NAV per share for the Sterling share class now up 3.9% over the calendar year to 27/09/2024, whilst the NAV per share for the US Dollar share class was up 3.2% over the same period.

In the interims, the manager of BH Macro Limited ("BH Macro") provides macro commentary covering the first half of the year. Rates were the main detractor during the first quarter, whilst digital assets and discount management (buybacks) were the main contributor. In Q2, rates and FX were both positive, to some extent offset by digital assets and equity.

Over the six months to 30/06/2024, assisted by BH Macro's share buyback programme that was initiated in December 2023, the discount narrowed from 10.71% (as at 31/12/2023) to 8.62% (as at 30/06/2024) for the Sterling share class, and similarly from 11.71% (as at 31/12/2023) to 9.29% (as at 30/06/2024) for the US Dollar share class. Since 30 June 2024, BH Macro has bought back a further 3.9m GBP shares, equating to 1.1% of the shares in issue. No USD shares have been bought back.

In BH Macro's Chairman's statement, chairman Richard Horlick notes: "The entire closed-ended fund sector is subject to greater pressure than at any other time in my more than 40 years' experience of it", noting that, "The Board remains convinced of the value of the Company and its strategy and the quality of the Manager and looks forward to delivering the highly diversifying positive returns, which the Company has delivered time and again over the past 17 years".

Kepler View

The Chairman notes the "highly diversifying" returns that BH Macro has delivered historically. In an equity market that has so far this year largely seen 'more of the same' positive momentum, it is perhaps not surprising that BH Macro's performance - which has traditionally been uncorrelated to equities - has not been noteworthy. That said, the market panic that global markets experienced during the first week of August gave us a helpful reminder of the diversifying potential that is underneath BH Macro's bonnet.

CLICK HERE TO READ THE FULL REPORT 

Visit Kepler Trust Intelligence for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP.  The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.  

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings